Loading clinical trials...
Loading clinical trials...
Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTrav® in Patients Previously Uncontrolled on a Beta-blocker
Conditions
Interventions
Beta-blocker monotherapy
Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution
Start Date
December 1, 2013
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
August 8, 2016
NCT07396441
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
Lead Sponsor
Alcon Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions